Apyx Medical (FRA:BOV) Cash And Cash Equivalents : €34.30 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Apyx Medical Cash And Cash Equivalents?

Apyx Medical's quarterly cash and cash equivalents increased from Sep. 2023 (€20.74 Mil) to Dec. 2023 (€40.03 Mil) but then stayed the same from Dec. 2023 (€40.03 Mil) to Mar. 2024 (€34.30 Mil).

Apyx Medical's annual cash and cash equivalents declined from Dec. 2021 (€27.32 Mil) to Dec. 2022 (€9.62 Mil) but then increased from Dec. 2022 (€9.62 Mil) to Dec. 2023 (€40.03 Mil).

Apyx Medical Cash And Cash Equivalents Historical Data

The historical data trend for Apyx Medical's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Cash And Cash Equivalents Chart

Apyx Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

52.93

34.45

27.32

9.62

40.03

Apyx Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															15.18	17.06	20.74	40.03	34.30

Apyx Medical Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Apyx Medical (FRA:BOV) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Apyx Medical Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Apyx Medical (FRA:BOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (FRA:BOV) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

APYX:USA

Address

5115 Ulmerton Road, Clearwater, FL, USA, 33760

Website

https://apyxmedical.com

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Apyx Medical (FRA:BOV) Headlines

No Headlines